• Neurotrophic Receptor Tyrosine Kinase 2 (NTRK2) Gene Mutation Analysis (Translocation)
  • Neurotrophic Receptor Tyrosine Kinase 3 (NTRK3) Gene Mutation Analysis (Translocation)
  • LiquidHALLMARK Multi Cancer Panel
  • NTRK Gene Fusion Panel (NTRK1, NTRK2, and NTRK3), Solid Tumors
  • Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq)
  • Tumor Suppressor Gene P53 (TP53) Gene Mutation Analysis
  • von Willebrand Factor Activity (Ristocetin Cofactor)
  • Lynch Syndrome Multi Gene Panel (MLH1, MSH2, MSH6, PMS2 and EPCAM), Genomic Unity®
  • DNA Cell Cycle Analysis by Flow Cytometry
  • Hemophilia A (F8) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
Medical Test

CPT
Access to OncoExTra (Oncomap™ ExTra) for Metastatic Cancer is restricted.
Loading...